Why Comfort Matters in a Booster Course

Regenerative skin boosters are built around polynucleotides — PDRN and PN, DNA fragments most commonly derived from salmon — which are used to support the skin's own repair processes rather than to add volume. They are placed into the skin rather than applied to it, because the molecules do not cross the barrier on their own.

That requirement is where the discomfort comes from, and it is worth being specific about why. A booster delivered by needle is placed as a series of small deposits across the treatment area, which can mean dozens of individual entry points in a single session. Each one passes through skin that has pain receptors and superficial vessels, so pinpoint bleeding, small raised bumps that take time to settle, bruising and swelling are ordinary rather than unusual. Topical anaesthetic reduces surface sensation but does not remove the sensation of the deposit itself.

None of this makes injected boosters a poor treatment. It does explain a practical problem clinics see constantly: regenerative results depend on completing a course, and patients who find the first session harder than expected frequently do not return for the second and third. A treatment that is not finished does not work, however good the formulation was.

That is the gap distributed delivery is intended to address — not by changing what the active ingredients do, but by changing how they get in.

What Is in ELREJU, and How It Is Delivered

ELREJU is formulated as a multi-component booster rather than a single-active product, with the composition intended to address several concerns within one session.

• PDRN and PN — polynucleotides, the regenerative core of the formulation, used to support repair and skin quality.
• Dual-weight hyaluronic acid — higher and lower molecular weight fractions intended to act at different levels, the lighter distributing more readily and the heavier holding water nearer the surface.
• Tranexamic acid and glutathione — included with tone and clarity in mind, which is what distinguishes a multi-function booster from one aimed at regeneration alone.
• Peptides and soothing agents such as madecassoside, included for barrier comfort.

Delivery is the other half of the design. Rather than being deposited as a bolus through a hypodermic needle, ELREJU is intended for distribution through a microneedle therapy system or the pump tips used with RF microneedling devices. The needles are fine and the depth is controlled, so the product is spread across the treatment area in many very small quantities rather than concentrated in fewer, deeper deposits.

The difference most patients notice is a shorter settling period — redness and warmth rather than raised bumps and pinpoint marks, generally calming within a day or two. Individual experience varies with skin sensitivity, the device used and the settings chosen, and some redness on the day should be expected regardless.

Injection or Microneedle: How Delivery Differs

Both routes are legitimate and both are in routine clinical use. They answer different priorities, and understanding the trade-off is more useful than being told one wins.

The important row is the last one. Where a practitioner needs a specific quantity of product at a specific depth — correcting a defined area rather than improving general skin quality — injection remains the appropriate route, and no delivery system replaces it. Where the aim is even improvement in hydration, tone and texture across a whole face, distributed delivery covers the area differently and with a gentler recovery. Which applies to you is a decision made at examination, not from a comparison table.

Who It Suits, and What to Know

Distributed-delivery boosters tend to be a reasonable match for:

• Anyone approaching regenerative treatment for the first time and uncertain about needles
• Reactive or easily irritated skin, where a gentler route is preferable
• People who cannot accommodate visible marks for several days around work or travel
• Those whose concern is overall skin quality — hydration, tone, texture — rather than one defined area

What it is not. It is not a replacement for treatment where depth and defined volume matter, and it does not act faster than the underlying biology allows. Polynucleotides support the skin's own repair over weeks, so this is a course rather than a single visit — commonly around three sessions a few weeks apart, with maintenance afterwards — and improvement is gradual. It does not lift, does not replace lost volume, and does not resolve established pigmentation on its own.

Comfort is relative, not absolute. Most patients find distributed delivery considerably more tolerable than bolus injection, but sensitivity varies and some redness, warmth and tightness on the day are normal. Anyone promising no sensation at all is overselling.

Standard cautions apply. Treatment is generally avoided during pregnancy and breastfeeding, over active skin infection or inflamed skin, and warrants discussion where there is a history of keloid scarring, an autoimmune condition, or a previous reaction to an injectable. Tell the clinic about every product you have had injected before and about current medications and supplements. Avoid heat, sauna, jjimjilbang and strenuous exercise for the rest of the day, keep the routine simple and sun protection diligent afterwards, and raise anything unexpected with the clinic rather than waiting.